Tags

Type your tag names separated by a space and hit enter

Cost considerations with tight glycemic control in the acute care setting.
Semin Thorac Cardiovasc Surg. 2006 Winter; 18(4):359-65.ST

Abstract

Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about 200 dollars per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than 6000 dollars (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.

Authors+Show Affiliations

Creighton University School of Pharmacy and Health Professions, Omaha, Nebraska, USA. hilleman@creighton.edu

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

17395033

Citation

Hilleman, Daniel E.. "Cost Considerations With Tight Glycemic Control in the Acute Care Setting." Seminars in Thoracic and Cardiovascular Surgery, vol. 18, no. 4, 2006, pp. 359-65.
Hilleman DE. Cost considerations with tight glycemic control in the acute care setting. Semin Thorac Cardiovasc Surg. 2006;18(4):359-65.
Hilleman, D. E. (2006). Cost considerations with tight glycemic control in the acute care setting. Seminars in Thoracic and Cardiovascular Surgery, 18(4), 359-65.
Hilleman DE. Cost Considerations With Tight Glycemic Control in the Acute Care Setting. Semin Thorac Cardiovasc Surg. 2006;18(4):359-65. PubMed PMID: 17395033.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cost considerations with tight glycemic control in the acute care setting. A1 - Hilleman,Daniel E, PY - 2006/12/20/accepted PY - 2007/3/31/pubmed PY - 2007/6/30/medline PY - 2007/3/31/entrez SP - 359 EP - 65 JF - Seminars in thoracic and cardiovascular surgery JO - Semin Thorac Cardiovasc Surg VL - 18 IS - 4 N2 - Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about 200 dollars per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than 6000 dollars (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs. SN - 1043-0679 UR - https://www.unboundmedicine.com/medline/citation/17395033/Cost_considerations_with_tight_glycemic_control_in_the_acute_care_setting_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1043-0679(07)00003-2 DB - PRIME DP - Unbound Medicine ER -